Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial

Introduction Current evidence on vascular access strategies for haemodialysis patients is based on observational studies that are at high risk of selection bias. For elderly patients, autologous arteriovenous fistulas that are typically created in usual care may not be the best option because a sign...

Full description

Saved in:
Bibliographic Details
Main Authors: Patrick WHE Vriens, Edith M Willigendael, Maarten A Lijkwan, Friedo W Dekker, Chava L Ramspek, Michiel W de Haan, Çaĝdaş Ünlü, Boudewijn DC Heggen, Koen E A van der Bogt, Marc H Hemmelder, Mickaël J C Hiligsmann, Magda M van Loon, Joris I Rotmans, Jan H M Tordoir, Geert Willem H Schurink, Maarten G J Snoeijs, Marijke J Molegraaf, Philippe WM Cuypers, Denise Nio, Cora H Arts, Jacobien C Verhave, Goos D Laverman, Aron S Bode, Marcel C Weijmer, Bas Govaert, Aaltje Y Adema, Gijs MJM Welten, Michel MPJ Reijnen, Marc JH Groeneveld, Hans S Brink, Jeroen B van der Net, Arno Kuijper, Hilde PE Peters, Roos C van Nieuwenhuizen, Rombout R Kruse, Yvonne C Schrama, Karina A de Groot, Karima Farhat
Format: Article
Language:English
Published: BMJ Publishing Group 2022-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/2/e053108.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823858062753005568
author Patrick WHE Vriens
Edith M Willigendael
Maarten A Lijkwan
Friedo W Dekker
Chava L Ramspek
Michiel W de Haan
Çaĝdaş Ünlü
Boudewijn DC Heggen
Koen E A van der Bogt
Marc H Hemmelder
Mickaël J C Hiligsmann
Magda M van Loon
Joris I Rotmans
Jan H M Tordoir
Geert Willem H Schurink
Maarten G J Snoeijs
Marijke J Molegraaf
Philippe WM Cuypers
Denise Nio
Cora H Arts
Jacobien C Verhave
Goos D Laverman
Aron S Bode
Marcel C Weijmer
Bas Govaert
Aaltje Y Adema
Gijs MJM Welten
Michel MPJ Reijnen
Marc JH Groeneveld
Hans S Brink
Jeroen B van der Net
Arno Kuijper
Hilde PE Peters
Roos C van Nieuwenhuizen
Rombout R Kruse
Yvonne C Schrama
Karina A de Groot
Karima Farhat
author_facet Patrick WHE Vriens
Edith M Willigendael
Maarten A Lijkwan
Friedo W Dekker
Chava L Ramspek
Michiel W de Haan
Çaĝdaş Ünlü
Boudewijn DC Heggen
Koen E A van der Bogt
Marc H Hemmelder
Mickaël J C Hiligsmann
Magda M van Loon
Joris I Rotmans
Jan H M Tordoir
Geert Willem H Schurink
Maarten G J Snoeijs
Marijke J Molegraaf
Philippe WM Cuypers
Denise Nio
Cora H Arts
Jacobien C Verhave
Goos D Laverman
Aron S Bode
Marcel C Weijmer
Bas Govaert
Aaltje Y Adema
Gijs MJM Welten
Michel MPJ Reijnen
Marc JH Groeneveld
Hans S Brink
Jeroen B van der Net
Arno Kuijper
Hilde PE Peters
Roos C van Nieuwenhuizen
Rombout R Kruse
Yvonne C Schrama
Karina A de Groot
Karima Farhat
collection DOAJ
description Introduction Current evidence on vascular access strategies for haemodialysis patients is based on observational studies that are at high risk of selection bias. For elderly patients, autologous arteriovenous fistulas that are typically created in usual care may not be the best option because a significant proportion of fistulas either fail to mature or remain unused. In addition, long-term complications associated with arteriovenous grafts and central venous catheters may be less relevant when considering the limited life expectancy of these patients. Therefore, we designed the Optimising Access Surgery in Senior Haemodialysis Patients (OASIS) trial to determine the best strategy for vascular access creation in elderly haemodialysis patients.Methods and analysis OASIS is a multicentre randomised controlled trial with an equal participant allocation in three treatment arms. Patients aged 70 years or older who are expected to initiate haemodialysis treatment in the next 6 months or who have started haemodialysis urgently with a catheter will be enrolled. To detect and exclude patients with an unusually long life expectancy, we will use a previously published mortality prediction model after external validation. Participants allocated to the usual care arm will be treated according to current guidelines on vascular access creation and will undergo fistula creation. Participants allocated to one of the two intervention arms will undergo graft placement or catheter insertion. The primary outcome is the number of access-related interventions required for each patient-year of haemodialysis treatment. We will enrol 195 patients to have sufficient statistical power to detect an absolute decrease of 0.80 interventions per year.Ethics and dissemination Because of clinical equipoise, we believe it is justified to randomly allocate elderly patients to the different vascular access strategies. The study was approved by an accredited medical ethics review committee. The results will be disseminated through peer-reviewed publications and will be implemented in clinical practice guidelines.Trial registration number NL7933.Protocol version and date V.5, 25 February 2021.
format Article
id doaj-art-902335e474734d7ebf31422a0cf064f7
institution Kabale University
issn 2044-6055
language English
publishDate 2022-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-902335e474734d7ebf31422a0cf064f72025-02-11T16:20:13ZengBMJ Publishing GroupBMJ Open2044-60552022-02-0112210.1136/bmjopen-2021-053108Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial 0Patrick WHE VriensEdith M WilligendaelMaarten A LijkwanFriedo W Dekker1Chava L Ramspek2Michiel W de Haan3Çaĝdaş Ünlü4Boudewijn DC Heggen5Koen E A van der Bogt6Marc H Hemmelder7Mickaël J C Hiligsmann8Magda M van Loon9Joris I Rotmans10Jan H M Tordoir11Geert Willem H Schurink12Maarten G J Snoeijs13Marijke J MolegraafPhilippe WM CuypersDenise NioCora H ArtsJacobien C VerhaveGoos D LavermanAron S BodeMarcel C WeijmerBas GovaertAaltje Y AdemaGijs MJM WeltenMichel MPJ ReijnenMarc JH GroeneveldHans S BrinkJeroen B van der NetArno KuijperHilde PE PetersRoos C van NieuwenhuizenRombout R KruseYvonne C SchramaKarina A de GrootKarima FarhatKenya National Bureau of Statistics, Nairobi, Nairobi, Kenyaprofessor of clinical epidemiologyDepartment of Clinical Epidemiology, Leiden University Medical Centre, Leiden, NetherlandsDepartment of Radiology, Maastricht University Medical Centre+, Maastricht, NetherlandsSurgery, Noordwest Ziekenhuisgroep, Alkmaar, NetherlandsDepartment of Vascular Surgery, Maastricht University Medical Centre+, Maastricht, NetherlandsDepartment of Surgery, Haaglanden Medical Centre, The Hague, NetherlandsDepartment of Internal Medicine, Division of Nephrology, Maastricht University Medical Centre+, Maastricht, NetherlandsDepartment of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, NetherlandsDepartment of Vascular Surgery, Maastricht University Medical Centre+, Maastricht, NetherlandsDepartment of Internal Medicine, Leiden University Medical Centre, Leiden, NetherlandsDepartment of Vascular Surgery, Maastricht University Medical Centre+, Maastricht, NetherlandsDepartment of Vascular Surgery, Maastricht University Medical Centre+, Maastricht, NetherlandsDepartment of Vascular Surgery, Maastricht University Medical Centre+, Maastricht, NetherlandsIntroduction Current evidence on vascular access strategies for haemodialysis patients is based on observational studies that are at high risk of selection bias. For elderly patients, autologous arteriovenous fistulas that are typically created in usual care may not be the best option because a significant proportion of fistulas either fail to mature or remain unused. In addition, long-term complications associated with arteriovenous grafts and central venous catheters may be less relevant when considering the limited life expectancy of these patients. Therefore, we designed the Optimising Access Surgery in Senior Haemodialysis Patients (OASIS) trial to determine the best strategy for vascular access creation in elderly haemodialysis patients.Methods and analysis OASIS is a multicentre randomised controlled trial with an equal participant allocation in three treatment arms. Patients aged 70 years or older who are expected to initiate haemodialysis treatment in the next 6 months or who have started haemodialysis urgently with a catheter will be enrolled. To detect and exclude patients with an unusually long life expectancy, we will use a previously published mortality prediction model after external validation. Participants allocated to the usual care arm will be treated according to current guidelines on vascular access creation and will undergo fistula creation. Participants allocated to one of the two intervention arms will undergo graft placement or catheter insertion. The primary outcome is the number of access-related interventions required for each patient-year of haemodialysis treatment. We will enrol 195 patients to have sufficient statistical power to detect an absolute decrease of 0.80 interventions per year.Ethics and dissemination Because of clinical equipoise, we believe it is justified to randomly allocate elderly patients to the different vascular access strategies. The study was approved by an accredited medical ethics review committee. The results will be disseminated through peer-reviewed publications and will be implemented in clinical practice guidelines.Trial registration number NL7933.Protocol version and date V.5, 25 February 2021.https://bmjopen.bmj.com/content/12/2/e053108.full
spellingShingle Patrick WHE Vriens
Edith M Willigendael
Maarten A Lijkwan
Friedo W Dekker
Chava L Ramspek
Michiel W de Haan
Çaĝdaş Ünlü
Boudewijn DC Heggen
Koen E A van der Bogt
Marc H Hemmelder
Mickaël J C Hiligsmann
Magda M van Loon
Joris I Rotmans
Jan H M Tordoir
Geert Willem H Schurink
Maarten G J Snoeijs
Marijke J Molegraaf
Philippe WM Cuypers
Denise Nio
Cora H Arts
Jacobien C Verhave
Goos D Laverman
Aron S Bode
Marcel C Weijmer
Bas Govaert
Aaltje Y Adema
Gijs MJM Welten
Michel MPJ Reijnen
Marc JH Groeneveld
Hans S Brink
Jeroen B van der Net
Arno Kuijper
Hilde PE Peters
Roos C van Nieuwenhuizen
Rombout R Kruse
Yvonne C Schrama
Karina A de Groot
Karima Farhat
Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial
BMJ Open
title Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial
title_full Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial
title_fullStr Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial
title_full_unstemmed Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial
title_short Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial
title_sort optimising access surgery in senior haemodialysis patients oasis study protocol for a multicentre randomised controlled trial
url https://bmjopen.bmj.com/content/12/2/e053108.full
work_keys_str_mv AT optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT patrickwhevriens optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT edithmwilligendael optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT maartenalijkwan optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT friedowdekker optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT chavalramspek optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT michielwdehaan optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT cagdasunlu optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT boudewijndcheggen optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT koeneavanderbogt optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT marchhemmelder optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT mickaeljchiligsmann optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT magdamvanloon optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT jorisirotmans optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT janhmtordoir optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT geertwillemhschurink optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT maartengjsnoeijs optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT marijkejmolegraaf optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT philippewmcuypers optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT denisenio optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT coraharts optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT jacobiencverhave optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT goosdlaverman optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT aronsbode optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT marcelcweijmer optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT basgovaert optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT aaltjeyadema optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT gijsmjmwelten optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT michelmpjreijnen optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT marcjhgroeneveld optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT hanssbrink optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT jeroenbvandernet optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT arnokuijper optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT hildepepeters optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT rooscvannieuwenhuizen optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT romboutrkruse optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT yvonnecschrama optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT karinaadegroot optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial
AT karimafarhat optimisingaccesssurgeryinseniorhaemodialysispatientsoasisstudyprotocolforamulticentrerandomisedcontrolledtrial